Argenx Se (ARGX) Other Non Operating Income (2016 - 2026)

Argenx Se (ARGX) posted Other Non Operating Income of -$11.0 million for Q1 2026, down 31.53% on a QoQ basis from -$8.4 million in Q4 2025, and down 140.74% year-over-year from $27.0 million in Q1 2025.

Argenx Se (ARGX) Other Non Operating Income (2016 - 2026) Analysis & Trends

Argenx Se's Other Non Operating Income history runs 11 years deep, the most recent figure standing at -$11.0 million for Q1 2026.

  • Quarterly Other Non Operating Income fell 140.74% year-over-year to -$11.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $27.4 million (up 1540.44% YoY) and the FY2025 annual result came in at $65.8 million, up 236.47% from the prior year.
  • Other Non Operating Income was -$11.0 million for Q1 2026 at Argenx Se, down from -$8.4 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $60.3 million in Q4 2022 and bottomed at -$54.9 million in Q4 2024.
  • A 5-year average of -$736235.3 and a median of -$7.2 million in 2022 frame the typical range for Other Non Operating Income.
  • Annual changes were most pronounced in 2022 — Other Non Operating Income slumped 542.15% — and 2025, when it jumped 714.51%.
  • Argenx Se's Other Non Operating Income stood at $60.3 million in 2022, then sank by 37.9% to $37.4 million in 2023, then sank by 246.78% to -$54.9 million in 2024, then soared by 84.77% to -$8.4 million in 2025, then sank by 31.53% to -$11.0 million in 2026.
  • Business Quant data shows ARGX's Other Non Operating Income at -$11.0 million in Q1 2026, -$8.4 million in Q4 2025, and -$1.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -11.00 Mn
Dec 31, 2025 -8.36 Mn
Sep 30, 2025 -1.85 Mn
Jun 30, 2025 48.57 Mn
Mar 31, 2025 27.00 Mn
Dec 31, 2024 -54.92 Mn
Sep 30, 2024 33.93 Mn
Jun 30, 2024 -7.90 Mn
Mar 31, 2024 -19.31 Mn
Dec 31, 2023 37.42 Mn
Sep 30, 2023 -32.51 Mn
Jun 30, 2023 -2.00 Mn
Mar 31, 2023 11.17 Mn
Dec 31, 2022 60.26 Mn
Sep 30, 2022 -39.61 Mn
Jun 30, 2022 -46.17 Mn
Mar 31, 2022 -7.21 Mn
Dec 31, 2021 -14.06 Mn
Sep 30, 2021 -17.62 Mn
Jun 30, 2021 10.44 Mn